On January 4, 2021 IDEAYA Biosciences, Inc. (Nasdaq:IDYA), an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics to treat cancer, reported its participation at the following upcoming investor relations events and scientific conferences (Press release, Ideaya Biosciences, JAN 4, 2021, View Source [SID1234573453]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Investor Relations Events

JP Morgan 39th Annual Healthcare Conference 2021 (Virtual)
Company Presentation
Wednesday, January 13th, 2021 at 5:20 pm ET
HC Wainwright Bioconnect (Virtual)
Company Presentation
Thursday, January 14th, 2021, at 6:00 am ET
A live audio webcast of each presentation will be available by visiting the "Investors/News and Events/Investor Calendar" section of the IDEAYA website at View Source A replay of the webcasts will be available for 30 days following the live event.

Scientific Conferences

PARP & DDR Inhibitors Summit 2021 (Digital)
Presentation Session – Next Generation Synthetic Lethal Interactions
"Pharmacological inhibition of DNA polymerase theta (Polq) activity shows promise as novel treatment for homologous recombination deficient tumors"
Thursday, January 28th, 2021 at 2:15 pm ET
The PARP & DDR Inhibitors Summit will be held January 26th-28th, 2021. See http://parp-ddr-inhibitors-summit.com/about/the-summit/.